THERAPEUTIC DRUG-MONITORING AS A STANDARD OF CARE

被引：6

作者：

MCLEOD, DC ^{[1
]}

TAYLOR, WJ ^{[1
]}

机构：

[1] UNIV S ALABAMA,COLL MED,DEPT NEUROL,MOBILE,AL 36617

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1985年 / 19卷 / 06期

关键词：

D O I：

10.1177/106002808501900611

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：473 / 474

页数：2

共 25 条

[1]

ANDERSON AC, 1976, ARCH INTERN MED, V136, P785

[2] ESTABLISHING AN AMINOGLYCOSIDE PHARMACOKINETIC MONITORING SERVICE IN A COMMUNITY-HOSPITAL [J].

BOLLISH, SJ ;

KELLY, WN ;

MILLER, DE ;

TIMMONS, RG .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (01) :73-76

[3] INDIVIDUALIZING GENTAMICIN DOSAGE REGIMENS IN BURN PATIENTS WITH GRAM-NEGATIVE SEPTICEMIA - COST-BENEFIT-ANALYSIS [J].

BOOTMAN, JL ;

WERTHEIMER, AI ;

ZASKE, D ;

ROWLAND, C .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (03) :267-272

[4] REDUCTION OF DIGOXIN TOXICITY ASSOCIATED WITH MEASUREMENT OF SERUM LEVELS - REPORT FROM BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM [J].

DUHME, DW ;

GREENBLATT, DJ ;

KOCHWESE.J .

ANNALS OF INTERNAL MEDICINE, 1974, 80 (04) :516-519

[5]

ELLENBAAS RM, 1980, AM J HOSP PHARM, V37, P61

[6]

GENTRY SM, 1981, AM J HOSP PHARM, V38, P1973

[7]

GREENLAW CN, 1981, AM J HOSP PHARM, V38, P1973

[8] A UTILIZATION REVIEW OF THEOPHYLLINE ASSAYS - SAMPLING PATTERNS AND USE [J].

GUERNSEY, BG ;

INGRIM, NB ;

HOKANSON, JA ;

FUCHS, JE ;

PROHASKA, C ;

DOUTRE, WH ;

BRYANT, SG ;

SIGLER, KA .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (11) :906-912

[9] AVOIDANCE OF ADVERSE-EFFECTS DURING CHRONIC THERAPY WITH THEOPHYLLINE [J].

HENDELES, L ;

WEINBERGER, M .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1980, 14 (7-8) :522-530

[10] REDUCTION OF DIGITALIS TOXICITY BY COMPUTER-ASSISTED GLYCOSIDE DOSAGE REGIMENS [J].

JELLIFFE, RW ;

KALABA, R ;

BUELL, J .

ANNALS OF INTERNAL MEDICINE, 1972, 77 (06) :891-+

← 1 2 3 →